Screening for Primary Open-Angle Glaucoma US Preventive Services Task Force Recommendation Statement

doi:10.1001/jama.2022.7013

Screening for Primary Open-Angle Glaucoma US Preventive Services Task Force Recommendation Statement

2022-05-24

29

OA

AI

DOI：10.1001/jama.2022.7013

Original

Original request for help

Save

Abstract

En 中文

IMPORTANCE Glaucoma affects an estimated 2.7 million people in the US. It is the second-leading cause of irreversible blindness in the US and the leading cause of blindness in Black and Hispanic/Latino persons. OBJECTIVE To update its 2013 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for glaucoma in adults. POPULATION Adults 40 years or older who present in primary care and do not have signs or symptoms of open-angle glaucoma. EVIDENCE ASSESSMENT The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of screening for glaucoma in adults. The benefits and harms of screening for glaucoma in adults are uncertain. More research is needed. RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults. (I statement)

Keywords:

UNITED-STATES

PREVALENCE

Screening for Primary Open-Angle Glaucoma US Preventive Services Task Force Recommendation Statement

Abstract

Journal

Organization